First Time Loading...

Bioretec Oy
F:0TN

Watchlist Manager
Bioretec Oy Logo
Bioretec Oy
F:0TN
Watchlist
Price: 2.49 EUR -1.97%
Updated: May 2, 2024

Wall Street
Price Targets

0TN Price Targets Summary
Bioretec Oy

Wall Street analysts forecast 0TN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0TN is 2.75 EUR with a low forecast of 2.72 EUR and a high forecast of 2.83 EUR.

Lowest
Price Target
2.72 EUR
9% Upside
Average
Price Target
2.75 EUR
10% Upside
Highest
Price Target
2.83 EUR
14% Upside
Bioretec Oy Competitors:
Price Targets
78W
Modulight Oyj
124% Upside
4737
Bionime Corp
77% Upside
CREO
Creo Medical Group PLC
186% Upside
SBS
Stratec SE
18% Upside
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
17% Upside
STE
STERIS plc
20% Upside
300298
Sinocare Inc
35% Upside
SRT
Sartorius AG
68% Upside

Revenue
Forecast

Revenue Estimate
Bioretec Oy

For the last 3 years the compound annual growth rate for Bioretec Oy's revenue is 19%. The projected CAGR for the next 4 years is 63%.

19%
Past Growth
63%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bioretec Oy

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0TN's stock price target?
Price Target
2.75 EUR

According to Wall Street analysts, the average 1-year price target for 0TN is 2.75 EUR with a low forecast of 2.72 EUR and a high forecast of 2.83 EUR.

What is Bioretec Oy's Revenue forecast?
Projected CAGR
63%

For the last 3 years the compound annual growth rate for Bioretec Oy's revenue is 19%. The projected CAGR for the next 4 years is 63%.